RETA-GLP3 40MG

Overview

Pepnova RETA-GLP3 40MG is a novel, research-focused peptide analog designed to explore incretin-related pathways. As part of the glucagon-like peptide family, it serves as a specialized tool for investigating metabolic regulation, insulin sensitivity, and potential effects on appetite and nutrient partitioning in experimental models.

Key Features & Benefits

• Novel Incretin Research Tool: Provides a distinct compound for studying pathways related to, but separate from, the more established GLP-1 and GLP-2 receptors.
• Metabolic Pathway Exploration: Enables investigation into glucose homeostasis, insulin modulation, and energy metabolism through novel mechanisms.
• High-Purity & Characterized: Synthesized to ≥ 99% purity (HPLC verified) with full mass spectrometry confirmation, ensuring a reliable and well-defined research compound.
• Stable Lyophilized Form: Provided as a sterile, freeze-dried powder for precise reconstitution and consistent handling in a laboratory setting.

Primary Research Applications

• Exploratory research into novel incretin receptor interactions and signaling.
• Study of compound effects on glucose tolerance and insulin sensitivity in preclinical models.
• Investigation of potential roles in appetite regulation and nutrient metabolism.
• Basic research to characterize the pharmacokinetic and pharmacodynamic profile of GLP-3 related compounds.

Product Specifications

• Unit Size: 40mg
• Compound: Retatrutide
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized (freeze-dried) powder
• Storage: Store in a cool, dry place. For long-term stability, refrigeration is recommended.

Important Notice

This product is for research and laboratory use only. It is not for human or veterinary consumption, diagnosis, or treatment. GLP-3RT is a research chemical whose biological activity is still being characterized; it should be handled by qualified personnel in a controlled research environment.